Unit galenical formulation for vaginal use as a local contraceptive and/or to combat sexually-transmitted diseases and/or HIV
AssigneeLaboratoire Innothera, Societe Anonyme
InventorCatherine Meignant
Life of this patent
Estimating the term…
Loading patent…
AssigneeLaboratoire Innothera, Societe Anonyme
InventorCatherine Meignant
Estimating the term…
This galenical formulation which comprises first an outer envelope including gelatin and secondly a non-aqueous liquid or semi-liquid internal phase containing an active principle in solution is characterized in that the active principle is constituted by a spermicide and in that the internal phase includes, in addition to the active principle: a major proportion of a lipophilic agent compatible with the rubber latex of a condom; in minor proportion at least one hydrodispersible agent; at least one bioadhesion agent; and at least one agent for gelling the lipophilic agent. This galenical formulation for vaginal use provides the known advantages of the soft capsule, having properties that are simultaneously spermicidal, antiseptic, and lubricating, and in addition it is reliably compatible with condoms, without any risk of damaging the rubber latex thereof.
A unit galenical formulation for vaginal use as a local contraceptive and/or to combat sexually-transmitted diseases and/or HIV, comprising firstly an outer envelope including gelatin and secondly a non-aqueous liquid or semi-liquid internal phase containing an active principle in solution, the formulation being characterized in that the active principle is constituted by a spermicide and in that the internal phase includes, in addition to the active principle:
Dependencies are inferred from the claim text.